Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Genesis Healthcare Inc (GEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 222,523
  • Shares Outstanding, K 154,530
  • Annual Sales, $ 5,732 M
  • Annual Income, $ -64,010 K
  • 36-Month Beta 1.17
  • Price/Sales 0.04
  • Price/Cash Flow 1.69
  • Price/Book 0.00

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.44 +4.17%
on 07/24/17
1.91 -21.47%
on 06/26/17
-0.38 (-20.21%)
since 06/23/17
3-Month
1.44 +4.17%
on 07/24/17
2.68 -44.03%
on 05/03/17
-0.87 (-36.71%)
since 04/24/17
52-Week
1.44 +4.17%
on 07/24/17
4.75 -68.42%
on 01/05/17
-0.69 (-31.51%)
since 07/22/16

Most Recent Stories

More News
Genmab reports on net sales of DARZALEX for Q2 2017

Biotechnology company Genmab A/S (CPH:GEN) reported on Tuesday that the worldwide net sales of DARZALEX (daratumumab), as reported by Johnson & Johnson, amounted to USD299m in Q2 2017.

GEN : 1.49 (+3.47%)
GNMSF : 224.5000 (-0.22%)
Eight Genesis HealthCare Centers Receive Silver National Quality Award

Genesis HealthCare, one of the nation's largest providers of post-acute care, today announced that eight of its Centers have been recognized as 2017 recipients of the Silver - Achievement in Quality Award....

GEN : 1.49 (+3.47%)
Six Genesis HealthCare Centers Receive Bronze National Quality Award

Genesis HealthCare, one of the nation's largest providers of post-acute care, today announced that six of its Centers have been recognized as 2017 recipients of the Bronze - Commitment to Quality Award...

GEN : 1.49 (+3.47%)
Genesis HealthCare Finalizes Agreement With U.S. Department of Justice

Genesis HealthCare, one of the nation's largest providers of post-acute care, has finalized its previously reported agreement with the U.S. Department of Justice and related government agencies to resolve...

GEN : 1.49 (+3.47%)
Genesis Healthcare Reports First Quarter 2017 Results

Genesis HealthCare (Genesis, or the Company) (NYSE:GEN), one of the largest post-acute care providers in the United States, today announced operating results for the first quarter ended March 31, 2017....

GEN : 1.49 (+3.47%)
Genesis HealthCare to Release First Quarter 2017 Results on Tuesday, May 9, 2017

Genesis HealthCare (NYSE:GEN), one of the nation's largest providers of post-acute care, today announced that it expects to release its first quarter ended March 31, 2017 results before the market opens...

GEN : 1.49 (+3.47%)
Kindred Issues 2017 Quality, Innovation and Social Responsibility Report

--Kindred Continues to Achieve High Clinical and Quality Outcomes Across All Service Lines

KND : 11.40 (-0.87%)
GEN : 1.49 (+3.47%)
American Renal Associates Holdings, Inc. Appoints Two New Members to Board of Directors

American Renal Associates Holdings, Inc. (NYSE: ARA) ("ARA" or the "Company"), a leading provider of outpatient dialysis services, today announced that Susanne (Susy) V. Clark and Robert...

ARA : 17.79 (-1.22%)
GEN : 1.49 (+3.47%)
New Strong Sell Stocks for March 17th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

GEN : 1.49 (+3.47%)
RRR : 24.42 (+2.01%)
STRA : 91.03 (-1.57%)
IRIX : 9.52 (-0.68%)
DZSI : 6.98 (-0.29%)
Genesis HealthCare to Present at the Barclays Global Healthcare Conference on March 16, 2017

Genesis HealthCare today announced that George V. Hager, Jr., Chief Executive Officer, and Tom DiVittorio, Chief Financial Officer, are scheduled to host a fireside chat at the Barclays Global Healthcare...

GEN : 1.49 (+3.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More

Business Summary

Genesis Healthcare, Inc. provides long-term care, assisted/senior living and rehabilitation therapy. Genesis Healthcare, Inc., formerly known as Skilled Healthcare Group, Inc., is based in Kennett Square, Pennsylvania.

See More

Support & Resistance

2nd Resistance Point 1.52
1st Resistance Point 1.48
Last Price 1.49
1st Support Level 1.42
2nd Support Level 1.40

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.